Press release
Escalating Diabetes Prevalence Drives The Global Glucagon-Like Peptide 1 Market: Strategic Insights Driving Glucagon-like Peptide 1 Market Momentum in 2025
Glucagon-like Peptide 1
How Large Will the Glucagon-like Peptide 1 Market Size By 2025?
The market size for glucagon-like peptide 1 has experienced robust growth in the past few years. It is projected to increase from $20.88 billion in 2024 to $22.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The substantial growth observed in the historic period can be credited to a surge in diabetes cases, emphasis on enhanced diabetes control, preference of patients towards injectable treatments, their clinical effectiveness and safety standards, as well as advancements in diabetic research.
How Big Is the Glucagon-like Peptide 1 Market Size Expected to Grow by 2029?
The market size of the glucagon-like peptide 1 is anticipated to witness significant expansion in the upcoming years, reaching a value of "$31.27 billion by 2029, boasting a compound annual growth rate (CAGR) of 8.7%. This anticipated surge can be attributed to the rise of oral GLP-1 treatments, an emphasis on tailored medical treatment, incorporation in diabetes treatment plans, and patient-oriented healthcare strategies. In the forecast period, key trends include market growth in developing economies, the green light for new formulas from regulatory bodies, a strong focus on personalized medicine, activities to educate and raise awareness among patients, and shifting dynamics in the competitive landscape.
View the full report here:
https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report
Which Key Market Drivers Powering Glucagon-like Peptide 1 Market Expansion and Growth?
The escalating occurrence of diabetes is anticipated to boost the worldwide market for glucagon-like peptide 1. Diabetes is characterized by elevated levels of blood sugar, also known as blood glucose. Glucagon-like peptide 1 is a pharmaceutical used to manage conditions like type 2 diabetes, which can result in weight loss and better blood sugar control. For example, the National Library of Medicine, a US-based hub for biomedical informatics and computational biology, stated in January 2022 that it was estimated that the global prevalence of diabetes among 20 to 79-year-olds in 2021 stood at 10.5% (536.6 million people). This figure is projected to rise to 12.2% (783.2 million people) in 2045. Consequently, the escalating incidence of diabetes is expected to stimulate the glucagon-like peptide 1 market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10830&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Glucagon-like Peptide 1 Market?
Technological advancements are a rising trend in the global glucagon-like peptide 1 market, with companies introducing innovative therapies to maintain their market presence. In March 2024, Denmark-based Novo Nordisk A/S launched Wegovy, the first once-weekly glucagon-like peptide 1 treatment for weight management. This product, having completed the STEP Phase 3a trials, demonstrated a safe profile and is intended for individuals managing obesity.
What Are the Emerging Segments in the Glucagon-like Peptide 1 Market?
The glucagon-like peptide 1 market covered in this report is segmented -
1) By Product: Trulicity, Ozempic, Victoza, Rybelsus, Other Types
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By End-Users: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Trulicity: Injection (pre-filled pen), Dosage forms (0.75 mg, 1.5 mg, etc.)
2) By Ozempic: Injection (pre-filled pen), Dosage forms (0.5 mg, 1 mg, etc.)
3) By Victoza: Injection (pre-filled pen), Dosage forms (1.2 mg, 1.8 mg, etc.)
4) By Rybelsus: Oral tablet (3 mg, 7 mg, 14 mg)
5) By Other Types: Experimental formulations, Combination products with other medications, Alternative delivery systems
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10830&type=smp
Who Are the Global Leaders in the Glucagon-like Peptide 1 Market?
Major companies operating in the glucagon-like peptide 1 market include Novo Nordisk AS, Sanofi SA, Eli Lilly and Co, AstraZeneca plc, Pfizer Inc, Boehringer Ingelheim International GmbH, F Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Baxter, Hikma Pharmaceuticals plc, Zealand Pharma A/S, Intarcia Therapeutics Inc., GlaxoSmithKline plc, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Benemae Pharmaceutical Corporation, Adocia, Biocon, Hanmi Pharmaceutical Co Ltd, Ligand Pharmaceuticals Incorporated, Advinus Therapeutics Ltd, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Union Chimique Belge, Amylin Pharmaceuticals LLC, Academic Pharmaceuticals Inc, ConjuChem Biotechnologies, MannKind Corporation:, Provention Bio Inc, Regeneron Pharmaceuticals
Which are the Top Profitable Regional Markets for the Glucagon-like Peptide 1 Industry?
North America was the largest region in the glucagon-like peptide 1 market in 2024. The regions covered in the glucagon-like peptide 1 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10830
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Escalating Diabetes Prevalence Drives The Global Glucagon-Like Peptide 1 Market: Strategic Insights Driving Glucagon-like Peptide 1 Market Momentum in 2025 here
News-ID: 4095903 • Views: …
More Releases from The Business Research Company
Dental Anesthesia Market Report Evaluates Growth Drivers, Challenges And Market …
The dental anesthesia sector is poised for significant growth as advancements in technology and evolving patient needs drive demand. With innovations improving safety and effectiveness, the market is expected to witness notable expansion over the coming years. Let's explore the current market size, key players, emerging trends, and segmentation that define the dental anesthesia industry today.
Projected Market Size and Growth Outlook for the Dental Anesthesia Industry
The dental anesthesia…
Demulcent Eye Drops Market Report Provides Insights Into Market Evolution And Gr …
The demulcent eye drops market is positioned for notable expansion in the coming years, driven by rising awareness about eye health and advances in product formulations. As consumers increasingly seek effective solutions for dry eye and related conditions, this market is expected to experience robust growth along several key dimensions.
Projected Market Value and Growth Outlook for Demulcent Eye Drops
By 2030, the demulcent eye drops market size is forecasted…
Deep Learning In Drug Discovery And Diagnostics Market Research Explores Growth …
The deep learning sector within drug discovery and diagnostics is rapidly evolving, driven by innovations that promise to transform healthcare. As artificial intelligence technologies become increasingly integrated into life sciences, the market is set to experience remarkable growth. Below, we explore the current market valuation, key players, emerging trends, and detailed segmentation to provide a comprehensive overview of this dynamic field.
Market Valuation Outlook for Deep Learning in Drug Discovery and…
Decentralized Trial Wearable Market Analysis Highlights Growth To $6.18 Billion …
The decentralized trial wearable industry is set to undergo remarkable expansion over the coming years, driven by technological advancements and evolving clinical research needs. This sector is increasingly attracting attention due to its potential to transform how clinical trials are conducted by enhancing remote patient monitoring and data accuracy. Let's explore the market's current outlook, key players, emerging trends, and the segments shaping its future trajectory.
Forecasted Market Value and Growth…
More Releases for Peptide
Peptide Pod Launches a New Platform Bringing Peptide Podcasts and Research Toget …
The world's first dedicated peptide podcast platform brings trusted education, research, and leading voices together in one place.
United States - August 10, 2026 - As interest in peptides continues to rise, finding trustworthy educational content has become increasingly difficult. New podcasts, research papers, and online discussions appear almost daily, leaving many people searching across multiple websites to stay informed. Peptide Pod [https://peptidepod.com/] is changing that by bringing peptide podcasts, research,…
Automated Microwave Peptide Synthesizer Market Innovation: Accelerating High-Thr …
The global Automated Microwave Peptide Synthesizer Market is witnessing robust growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt automated peptide synthesis technologies to accelerate drug discovery and development. Automated microwave peptide synthesizers have transformed peptide manufacturing by significantly reducing synthesis time while improving reaction efficiency, reproducibility, and product quality. As peptide-based therapeutics continue gaining prominence across modern medicine, demand for advanced synthesis platforms is expanding rapidly.
According to…
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity.
United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity.
The platform gives researchers access to more than 30 research compounds, each independently tested by third-party…
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg
Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity.
This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
